JP2003246730A5 - - Google Patents

Download PDF

Info

Publication number
JP2003246730A5
JP2003246730A5 JP2002046613A JP2002046613A JP2003246730A5 JP 2003246730 A5 JP2003246730 A5 JP 2003246730A5 JP 2002046613 A JP2002046613 A JP 2002046613A JP 2002046613 A JP2002046613 A JP 2002046613A JP 2003246730 A5 JP2003246730 A5 JP 2003246730A5
Authority
JP
Japan
Prior art keywords
tryptase
guanidinobenzoate
amidino
mesylate
naphthyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002046613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003246730A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002046613A priority Critical patent/JP2003246730A/ja
Priority claimed from JP2002046613A external-priority patent/JP2003246730A/ja
Priority to PCT/JP2003/001814 priority patent/WO2003070235A1/ja
Priority to AU2003211540A priority patent/AU2003211540A1/en
Priority to TW092103438A priority patent/TW200306811A/zh
Publication of JP2003246730A publication Critical patent/JP2003246730A/ja
Publication of JP2003246730A5 publication Critical patent/JP2003246730A5/ja
Pending legal-status Critical Current

Links

JP2002046613A 2002-02-22 2002-02-22 トリプターゼ阻害剤 Pending JP2003246730A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002046613A JP2003246730A (ja) 2002-02-22 2002-02-22 トリプターゼ阻害剤
PCT/JP2003/001814 WO2003070235A1 (en) 2002-02-22 2003-02-19 Medicinal compositions for inhibiting tryptase
AU2003211540A AU2003211540A1 (en) 2002-02-22 2003-02-19 Medicinal compositions for inhibiting tryptase
TW092103438A TW200306811A (en) 2002-02-22 2003-02-19 Medicinal compositions for inhibiting tryptase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002046613A JP2003246730A (ja) 2002-02-22 2002-02-22 トリプターゼ阻害剤

Publications (2)

Publication Number Publication Date
JP2003246730A JP2003246730A (ja) 2003-09-02
JP2003246730A5 true JP2003246730A5 (enExample) 2005-08-25

Family

ID=27750646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002046613A Pending JP2003246730A (ja) 2002-02-22 2002-02-22 トリプターゼ阻害剤

Country Status (4)

Country Link
JP (1) JP2003246730A (enExample)
AU (1) AU2003211540A1 (enExample)
TW (1) TW200306811A (enExample)
WO (1) WO2003070235A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005120491A1 (ja) * 2004-06-14 2005-12-22 Torii Pharmaceutical Co., Ltd. 炎症性腸疾患の治療薬又は予防薬
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
EP1884237B1 (en) * 2005-05-17 2010-12-08 Santen Pharmaceutical Co., Ltd. Amidino derivatives for use in the prevention or treatment of glaucoma
JP2007186457A (ja) * 2006-01-13 2007-07-26 Ichimaru Pharcos Co Ltd トリプターゼ活性阻害剤およびその利用
GB2445920A (en) * 2007-01-25 2008-07-30 Mucokinetica Ltd Amidino compounds for treatment of respiratory disease
CN106580961A (zh) * 2016-12-07 2017-04-26 郑州仁宏医药科技有限公司 一种用于治疗特发性肺纤维化的西药组合及其应用
CR20200394A (es) * 2018-02-09 2020-11-05 Genentech Inc Métodos terapéuticos y diagnósticos para enfermedades inflrmatorias mediadas por mostocitos
US20230190697A1 (en) * 2020-03-31 2023-06-22 Ensysce Biosciences, Inc. Methods for treating viral infections with nafamostat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5753454A (en) * 1980-09-16 1982-03-30 Torii Yakuhin Kk Guanidinobenzoate and anticomplementary agent
KR20000005312A (ko) * 1996-04-10 2000-01-25 오노 야꾸힝 고교 가부시키가이샤 트립타아제 억제제 및 신규 구아니디노 유도체

Similar Documents

Publication Publication Date Title
JP2021063088A5 (enExample)
JP2020507589A5 (enExample)
JP2010522242A5 (enExample)
JP2009280627A5 (enExample)
JP2011528713A5 (enExample)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
JP2012525393A5 (enExample)
JP2017057230A5 (enExample)
JP2009535352A5 (enExample)
JP2004525179A5 (enExample)
JP2005500357A5 (enExample)
JP2005525345A5 (enExample)
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
JP2019516739A5 (enExample)
JP2015524444A5 (enExample)
RU2005126412A (ru) Сор1 для лечения воспалительных заболеваний кишечника
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
JP2005508337A5 (enExample)
RU2011117927A (ru) Карбаматное соединение или его соль
JP2008513510A5 (enExample)
JP2008510758A5 (enExample)
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
JP2010505865A5 (enExample)
JPWO2023195530A5 (enExample)
JP2003246730A5 (enExample)